Literature DB >> 9458163

Identification of the end stage of scrapie using infected neural grafts.

S Brandner1, S Isenmann, G Kühne, A Aguzzi.   

Abstract

Although the formal pathogenesis of spongiform encephalopathies has been described in detail, it is not known whether the infectious agent targets primarily neurons, glial cells, or both. To address this question, we have transplanted transgenic embryonic neural tissue overexpressing PrP(c) into the forebrain of Prnp -knockout mice, and infected it with scrapie prions. After infection, grafts developed severe spongiform encephalopathy. As the infected hosts were not clinically affected, we were able to prolong the experiment and to assess changes in the graft over periods of time, which vastly exceeded the normal life span of scrapie-infected mice. Sequential contrast-enhanced magnetic resonance imaging (MRI) revealed progressive impairment of blood-brain barrier properties in infected grafts. However, loss of astrocytes was not observed. Subtotal neuronal loss occurred during the progression of the disease in the grafts, reactive astrocytes persisted until the terminal stage of disease. We conclude that scrapie encephalopathy primarily leads to neuronal death, while degeneration of astrocytes does not occur. Functional impairment of the blood-brain barrier suggests involvement of astrocytes and endothelial cells in the pathological process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9458163     DOI: 10.1111/j.1750-3639.1998.tb00130.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  10 in total

1.  Brain-water diffusion coefficients reflect the severity of inherited prion disease.

Authors:  H Hyare; S Wroe; D Siddique; T Webb; N C Fox; J Stevens; J Collinge; T Yousry; J S Thornton
Journal:  Neurology       Date:  2010-02-23       Impact factor: 9.910

2.  Neuronal low-density lipoprotein receptor-related protein 1 binds and endocytoses prion fibrils via receptor cluster 4.

Authors:  Angela Jen; Celia J Parkyn; Roy C Mootoosamy; Melanie J Ford; Alice Warley; Qiang Liu; Guojun Bu; Ilia V Baskakov; Søren Moestrup; Lindsay McGuinness; Nigel Emptage; Roger J Morris
Journal:  J Cell Sci       Date:  2010-01-15       Impact factor: 5.285

Review 3.  Grafting mouse brains: from neurocarcinogenesis to neurodegeneration.

Authors:  A Aguzzi
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

4.  Normal neurogenesis and scrapie pathogenesis in neural grafts lacking the prion protein homologue Doppel.

Authors:  A Behrens; S Brandner; N Genoud; A Aguzzi
Journal:  EMBO Rep       Date:  2001-04       Impact factor: 8.807

5.  Flow Cytometric Detection of PrPSc in Neurons and Glial Cells from Prion-Infected Mouse Brains.

Authors:  Takeshi Yamasaki; Akio Suzuki; Rie Hasebe; Motohiro Horiuchi
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

6.  Establishment of astrocyte cell lines from sheep genetically susceptible to scrapie.

Authors:  D Vilette; M F Madelaine; H Laude
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-01       Impact factor: 2.416

7.  When amyloids become prions.

Authors:  Raimon Sabate
Journal:  Prion       Date:  2014-05-15       Impact factor: 3.931

8.  Recent developments in the pathogenesis, diagnosis, and therapy of prion diseases.

Authors:  A Aguzzi
Journal:  Dialogues Clin Neurosci       Date:  2001-03       Impact factor: 5.986

Review 9.  Prions and prion-like pathogens in neurodegenerative disorders.

Authors:  Caterina Peggion; Maria Catia Sorgato; Alessandro Bertoli
Journal:  Pathogens       Date:  2014-02-18

10.  Characterisation of radioiodinated flavonoid derivatives for SPECT imaging of cerebral prion deposits.

Authors:  Takeshi Fuchigami; Yuki Yamashita; Masao Kawasaki; Ayaka Ogawa; Mamoru Haratake; Ryuichiro Atarashi; Kazunori Sano; Takehiro Nakagaki; Kaori Ubagai; Masahiro Ono; Sakura Yoshida; Noriyuki Nishida; Morio Nakayama
Journal:  Sci Rep       Date:  2015-12-16       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.